[THE CONCEPT OF "MOTORIST APTITUDE" IN LEGAL AND MEDICOPSYCHOLOGICAL CONTEXT].
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This article explores issues related to automobile driving and dementia from the perspective of an outpatient medical clinic. A retrospective pilot study is presented with particular focus on the relationship between cognitive status and hazardous driving performance. Special attention is given to the practice considerations that confront social workers and other health care professionals who deal with this prevalent and difficult problem.
The extent to which caffeine antagonizes alcohol-induced impairment of simulated automobile driving at the current lowest legal American limit (0.08% BrAC) was the focus of this study. Fifteen adults swallowed a capsule (0, 200, or 400 mg caffeine) then drank a beverage (0.0 or 0.6 g/kg ethanol) in a within-subject, double-blind, randomized procedure. Forty-five minutes later, participants completed a test battery of subjective effects scales, dynamic posturography, critical flicker fusion (CFF), choice reaction time (CRT), divided attention (Stroop test), and simulated driving. Alcohol alone increased ratings of 'dizzy', 'drug effect', and 'high', slowed CRT and brake latency, and increased body sway. Caffeine alone increased ratings of 'alert' and 'jittery', but did not significantly affect body sway or psychomotor performance. Both caffeine doses comparably counteracted alcohol impairment of brake latency but not CRT or body sway. Brake latency with either alcohol-caffeine combination remained significantly longer than that with placebo. Stroop and CFF performance were unaffected by any drug condition. The results suggest that caffeine may increase alertness and improve reaction time after alcohol use but will not completely counteract alcohol impairment in a driver.
Historically, persons with seizures or epilepsy have been prohibited from driving automobiles or motor vehicles because of concern for public safety. Seizures have a tendency to recur and pose risks of traffic accidents, property damage, and personal injury. In our modern world, however, driving an automobile is such an economic and social necessity that a conflict results between our need to protect public safety and our responsibility to provide reasonable opportunities to drive for persons handicapped by seizures and epilepsy. Currently, there is a trend toward liberalization of driving standards for persons with epilepsy, but there is still considerable controversy regarding the specific driving restrictions necessary for persons with seizures, the way in which such policies should be administered, and the role physicians should have in the process.
Explore the source record for details and available documents.
Alzheimer disease (AD) affects several abilities that are crucial to automobile driving and can thereby increase the risk for a crash. The specific driver safety errors that lead up to crashes in this driver population, however, remain largely unknown. We developed a graphical means for dissecting these safety-related behaviors for application to car crashes of AD drivers. These crashes occurred in collision avoidance scenarios implemented on the Iowa Driving Simulator. Crash plots were produced by "rewinding" the data stream, then graphing the vehicle speed, path, steering wheel position, pedal positions, and driver gaze up to the very moment of impact. In this way, we were able to display in detail the patterns of vehicle and driver control to determine exactly how a crash occurred. Several different types of antecedent safety errors were noted, ranging from responding inappropriately with the hand and foot controls to not responding at all. In this paper we focus on the performance of a single impaired driver to demonstrate our technique and findings. Understanding the "anatomy" of crashes in cognitively disabled drivers with AD can help guide future efforts at injury prevention and control.
The effect of organismic variable age on human cognitive performance was studied under the impact of vibration in different automobile driving environments, namely city streets, rural roads and highways. Reaction time was measured in milliseconds through a human response measurement system specifically designed for the purpose. Results of the study showed that age had a significant effect in city street and rural road conditions. It was also found that the level of equivalent acceleration of vibration and a difficulty index significantly affected cognitive performance in all driving conditions. The organismic variable age observed to have a significant effect on task performance implied that youngsters and older people are stressed differently in specific environments of driving so proper stress management strategies should be evolved for them in order to minimize the number of accidents.
Twelve healthy young men were assessed in each of four experimental conditions presented in a Latin Square design: 8-hr time in bed (TIB) and placebo, 4-hr TIB and placebo, 8-hr TIB and ethanol, and 4-hr TIB and ethanol. After consuming ethanol (0.6 g/kg) or placebo (0900-0930 hr) with 20% supplements at 1030 and 1100 hr, subjects were tested for sleepiness (Multiple Sleep Latency Test at 1000, 1200, 1400, and 1600 hr) and divided attention (1030 hr) performance on day 1, and for simulated driving and divided attention (1000-1200 and 1400-1600 hr) performance on day 2. In the morning testing, with breath ethanol concentrations (BECs) averaging 0.049%, sleepiness was increased, divided attention reaction times increased (on both days), and simulated driving performance was disturbed in the ethanol and 4-hr TIB relative to placebo. Similarly in the afternoon, with BECs averaging 0.013%, the ethanol and 4-hr TIB condition increased sleepiness and disrupted divided attention and simulated driving performance. The results show that sleepiness and low-dose ethanol combine to impair simulated automobile driving, an impairment that extends beyond the point at which BEC reaches zero. They provide a possible explanation for the incidence of alcohol-related automobile accidents at low BECs.
Time variant processes of activity, activation and strain of man are registrated during several hours of automobil driving (highway-autobahn) for different stress conditions and classified in terms of degrees of fatigue. By comparison with an assessment of strain in a simulated driving task with the same individuum and the same research-methods it is shown that the development of methods for measurement and assessment of time-variant human processes in laboratory experiments can be recommended, field-studies higher degrees of strain were found than under laboratory conditions.
The effect of physiologic (100 mg/wk) and supraphysiologic (250 and 500 mg/wk) doses of testosterone cypionate (TC) on automobile driving were studied using the Iowa Driver Simulator. Six normal subject volunteers were studied off TC and on TC once steady-state concentrations were achieved after at least three weeks of dosing. Despite the administration of supraphysiologic testosterone doses, an increase in aggressive driving behavior was not detected. Likewise, corresponding psychometric testing using the Buss-Durkee Hostility Inventory to assess aggression was unable to detect any change in aggression in the test subjects. Although aggressive driving behavior may be increased by testosterone administration, the drug itself may not be responsible for these effects. Supraphysiologic doses greater than 500 mg/wk and a semi-controlled research environment may be necessary to produce this effect since case reports of AAS abuse causing altered driving behavior may be multifactorial in nature.
HIV infection often results in neuropsychological (NP) impairment. In order to assess the impact that HIV-related NP deficits may have on automobile driving, we evaluated 68 HIV-seropositive drivers using an NP battery and two PC-based driving simulations. Thirty-two participants were classified as NP impaired; most (72%) evidenced only mild impairment, and none met criteria for HIV-associated dementia. After controlling for degree of immunosuppression and disease stage, NP-impaired participants failed a previously validated driving simulation at a much higher rate than cognitively intact participants [OR = 5.3, 95% CI (1.7, 17.0), p = .006]. Similarly, on a simulation of city driving, NP impaired participants were more likely to fail based upon the number of accidents [OR = 6.1, 95% CI (1.5, 24.6), p = .01]. Simulator performance was predicted by functioning in a number of NP domains, with NP tests accounting for 13-30% of the variance on the simulations. Although it would be premature to extrapolate these findings to impairment in on-the-road driving, they do argue for greater attention to the impact that even mild HIV-related NP deficits may have on driving skills.
Explore the source record for details and available documents.